文献速递骨肌泌尿生殖技术与安全MR

全身MRI评估前列腺癌和多发性骨髓瘤骨受累:T1、短tau反转恢复(STIR)和高b值扩散加权成像(DWI)序列诊断准确性的比较

Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences.
PubMed 文献 · Eur Radiol · 2018-11-09

本研究纳入50例高危转移前列腺癌患者和47例组织学确诊的多发性骨髓瘤患者,于2015年1月至12月在两家机构接受全身MRI,比较T1、STIR、高b值DWI及序列组合检测骨受累的诊断准确性。前列腺癌组中T1-DWI、T1-STIR和T1-STIR-DWI表现最高(敏感度100%,特异度100%);骨髓瘤组中T1-STIR-DWI表现最高(敏感度100%,特异度94.1%)。结论认为前列腺癌中T1-DWI或T1-STIR组合不劣于三序列组合,骨髓瘤中T1-STIR-DWI和T1-DWI诊断表现最高。

要点

  • 前列腺癌组中T1-DWI、T1-STIR和T1-STIR-DWI的敏感度和特异度均达100%。
  • 骨髓瘤组中T1-STIR-DWI敏感度100%、特异度94.1%,为最高表现。
  • 骨髓瘤组中T1-STIR-DWI显著优于除T1-DWI外的所有序列(p<0.05)。

核心结论

  • 前列腺癌患者中T1-DWI或T1-STIR序列组合检测骨转移不劣于三序列组合;骨髓瘤中T1-STIR-DWI和T1-DWI检测骨受累诊断表现最高。

研究设计与样本

  • 研究纳入50例高危转移前列腺癌患者和47例组织学确诊的多发性骨髓瘤患者,2015年1月至12月在两家机构接受全身MRI,采集冠状T1、STIR和重建冠状高b值DWI,由两名肌骨放射科医生阅读单序列、序列对(T1-DWI、T1-STIR、STIR-DWI)及全部组合(T1-STIR-DWI),以结合基线和6个月影像及临床生物学数据的「最佳有价值比较标准」用ROC曲线分析评估诊断性能并计算观察者间一致性。

诊断标准与关键数值

  • 前列腺癌组中T1-DWI、T1-STIR和T1-STIR-DWI敏感度100%(95%CI 90.5-100%)、特异度100%(95%CI 75.3-100%);骨髓瘤组中T1-STIR-DWI敏感度100%(95%CI 88.4-100%)、特异度94.1%(95%CI 71.3-100%)。

临床应用与阅片要点

  • 前列腺癌患者中T1-DWI或T1-STIR序列组合检测骨转移不劣于三序列组合;骨髓瘤中T1-STIR-DWI和T1-DWI检测骨受累诊断表现最高。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To compare the diagnostic accuracy of whole-body T1, short tau inversion recovery (STIR), high b-value diffusion-weighted imaging (DWI), and sequence combinations to detect bone involvement in prostate cancer (PCa) and multiple myeloma (MM) patients.

MATERIALS AND METHODS: We included 50 consecutive patients with PCa at high risk for metastasis and 47 consecutive patients with a histologically confirmed diagnosis of MM who received whole-body MRI at two institutions from January to December 2015. Coronal T1, STIR, and reconstructed coronal high b-values DWI were obtained for all patients. Two musculoskeletal radiologists read individual sequences, pairs of sequences (T1-DWI, T1-STIR, and STIR-DWI), and all combined (T1-STIR-DWI) to detect bone involvement. Receiver operating characteristic curve analysis was used to assess diagnostic performance according to a "best valuable comparator" combining baseline and 6-month imaging and clinical and biological data. Interobserver agreement was calculated.

RESULTS: Interobserver agreement for individual and combined MRI sequences was very good in the PCa group and ranged from good to very good in the MM group (0.76-1.00). In PCa patients, T1-DWI, T1-STIR, and T1-STIR-DWI showed the highest performance (sensitivity = 100% [95% CI = 90.5-100%], specificity = 100% [75.3-100%]). In MM patients, the highest performance was achieved by T1-STIR-DWI (sensitivity = 100% [88.4-100%], specificity = 94.1% [71.3-100%]). T1-STIR-DWI significantly outperformed all sequences (p < 0.05) except T1-DWI (p = 0.49).

CONCLUSION: In PCa patients, a combination of either T1-DWI or T1-STIR sequences is not inferior to a combination of three sequences to detect bone metastases. In MM, T1-STIR-DWI and T1-DWI had the highest diagnostic performance for detecting bone involvement.

KEY POINTS: • The sequences used in Whole Body MRI studies to detect bone involvement in prostate cancer and myeloma were evaluated. • In prostate cancer, any pairwise combinations of T1, STIR, and DWI have high diagnostic value. • In myeloma, the combinations T1-STIR-DWI or T1-DWI sequences should be used.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Larbi A, Omoumi P, Pasoglou V, et al. Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences. Eur Radiol. 2018. PMID: 30413957. doi:10.1007/s00330-018-5796-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。